EMA Authorised: Ongentys (opicapone) — Bial - Portela Cª, S.A.

View source ↗

Summary

EMA authorised Ongentys (opicapone) by Bial - Portela Cª, S.A. for Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ONGENTYS (opicapone)

Snippet

Status: Authorised. Therapeutic area: Parkinson Disease. MAH: Bial - Portela Cª, S.A.. Decision date: 11/07/2024